Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes

Published:2017-02-23 Issue:6 Volume:19 Page:850-857
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Anholm Christian¹²^ORCID,Kumarathurai Preman²,Pedersen Lene R.²,Nielsen Olav W.²,Kristiansen Ole P.²,Fenger Mogens³,Madsbad Sten⁴,Sajadieh Ahmad²,Haugaard Steen B.¹⁵

Affiliation:

1. Department of Internal Medicine; Copenhagen University Hospital; Amager Denmark

2. Department of Cardiology; Copenhagen University Hospital; Bispebjerg Denmark

3. Department of Clinical Biochemistry; Copenhagen University Hospital; Hvidovre Denmark

4. Department of Endocrinology; Copenhagen University Hospital; Hvidovre Denmark

5. Clinical Research Centre; Copenhagen University Hospital; Hvidovre Denmark

Funder

Novo Nordisk

Hjerteforeningen

The AP Møller Foundation

Department of Internal Medicine, Amager Hospital

Clinical Research Centre, Hvidovre Hospital

Bispebjerg Hospital Research Foundation

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12891/fullpdf

Reference44 articles.

1. Excess mortality among persons with type 2 diabetes;Tancredi;N Engl J Med,2015

2. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes;Morrish;Diabetologia,2001

3. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people;Schramm;Circulation,2008

4. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

5. Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus;Sauer;Am J Cardiol,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus;Clinical Nutrition;2024-08

2. Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus;Diabetes Research and Clinical Practice;2023-03

3. The Role of Beta Cell Recovery in Type 2 Diabetes Remission;International Journal of Molecular Sciences;2022-07-04

4. Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women;Frontiers in Endocrinology;2021-11-17

5. Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide;Diabetes, Obesity and Metabolism;2021-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3